Key findings Public drug programs spent $16.2 billion in 2021, a 7.4% increase from 2020 (the highest growth rate since 2018)
Transdermal-specific considerations for patches would include: Local skin reactions (erythema, itching, irritation at application site) Contact dermatitis from adhesive components or penetration enhancers Skin integrity concerns requiring regular site rotation Patient safety advice for anyone using GLP-1 therapy includes: Report persistent severe abdominal pain (potential pancreatitis) Monitor for signs of gallbladder problems (right upper quadrant pain, particularly after meals) Maintain adequate hydration, especially if experiencing vomiting or diarrhoea Contact your GP if side effects are severe, persistent, or concerning Report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) Regarding pregnancy and breastfeeding, advice varies by product
The therapeutic efficacy of liraglutide appears consistent regardless of the severity of the underlying MC4R deficiency
SBGJ202102162)
Understanding Potential Issues of Weight Loss Surgery Bariatric surgery can be a safe and effective intervention for weight loss management when other methods have been unsuccessful
Sagging skin, reduced fat padding and visible tendons or veins in the feet